These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 19325703)
1. HIV aspartyl peptidase inhibitors interfere with cellular proliferation, ultrastructure and macrophage infection of Leishmania amazonensis. Santos LO; Marinho FA; Altoé EF; Vitório BS; Alves CR; Britto C; Motta MC; Branquinha MH; Santos AL; d'Avila-Levy CM PLoS One; 2009; 4(3):e4918. PubMed ID: 19325703 [TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of HIV peptidase inhibitors on Fonsecaea pedrosoi: promising compounds to arrest key fungal biological processes and virulence. Palmeira VF; Kneipp LF; Rozental S; Alviano CS; Santos AL PLoS One; 2008; 3(10):e3382. PubMed ID: 18852883 [TBL] [Abstract][Full Text] [Related]
3. Lopinavir, an HIV-1 peptidase inhibitor, induces alteration on the lipid metabolism of Leishmania amazonensis promastigotes. Rebello KM; Andrade-Neto VV; Zuma AA; Motta MCM; Gomes CRB; de Souza MVN; Atella GC; Branquinha MH; Santos ALS; Torres-Santos EC; d'Avila-Levy CM Parasitology; 2018 Sep; 145(10):1304-1310. PubMed ID: 29806577 [TBL] [Abstract][Full Text] [Related]
4. Decoding the anti-Trypanosoma cruzi action of HIV peptidase inhibitors using epimastigotes as a model. Sangenito LS; Menna-Barreto RF; D Avila-Levy CM; Santos AL; Branquinha MH PLoS One; 2014; 9(12):e113957. PubMed ID: 25464510 [TBL] [Abstract][Full Text] [Related]
5. Primary evidence of the mechanisms of action of HIV aspartyl peptidase inhibitors on Trypanosoma cruzi trypomastigote forms. Sangenito LS; Menna-Barreto RFS; Oliveira AC; d'Avila-Levy CM; Branquinha MH; Santos ALS Int J Antimicrob Agents; 2018 Aug; 52(2):185-194. PubMed ID: 29635008 [TBL] [Abstract][Full Text] [Related]
6. Effects of HIV aspartyl-proteinase inhibitors on Leishmania sp. Valdivieso E; Rangel A; Moreno J; Saugar JM; Cañavate C; Alvar J; Dagger F Exp Parasitol; 2010 Dec; 126(4):557-63. PubMed ID: 20566367 [TBL] [Abstract][Full Text] [Related]
7. Intracellular survival of Leishmania species that cause visceral leishmaniasis is significantly reduced by HIV-1 protease inhibitors. Trudel N; Garg R; Messier N; Sundar S; Ouellette M; Tremblay MJ J Infect Dis; 2008 Nov; 198(9):1292-9. PubMed ID: 18816190 [TBL] [Abstract][Full Text] [Related]
8. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections]. Pozio E Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694 [TBL] [Abstract][Full Text] [Related]
9. Nelfinavir is effective in inhibiting the multiplication and aspartic peptidase activity of Leishmania species, including strains obtained from HIV-positive patients. Santos LO; Vitório BS; Branquinha MH; Pedroso e Silva CM; Santos AL; d'Avila-Levy CM J Antimicrob Chemother; 2013 Feb; 68(2):348-53. PubMed ID: 23109184 [TBL] [Abstract][Full Text] [Related]
10. Lopinavir and Nelfinavir Induce the Accumulation of Crystalloid Lipid Inclusions within the Reservosomes of Sangenito LS; Pereira MG; Souto-Padron T; Branquinha MH; Santos ALS Trop Med Infect Dis; 2021 Jul; 6(3):. PubMed ID: 34287373 [TBL] [Abstract][Full Text] [Related]
11. Aspartic peptidases of human pathogenic trypanosomatids: perspectives and trends for chemotherapy. Santos LO; Garcia-Gomes AS; Catanho M; Sodre CL; Santos AL; Branquinha MH; d'Avila-Levy CM Curr Med Chem; 2013; 20(25):3116-33. PubMed ID: 23298141 [TBL] [Abstract][Full Text] [Related]
15. Antileishmanial activity of a naphthoquinone derivate against promastigote and amastigote stages of Leishmania infantum and Leishmania amazonensis and its mechanism of action against L. amazonensis species. Mendonça DVC; Lage DP; Calixto SL; Ottoni FM; Tavares GSV; Ludolf F; Chávez-Fumagalli MA; Schneider MS; Duarte MC; Tavares CAP; Alves RJ; Coimbra ES; Coelho EAF Parasitol Res; 2018 Feb; 117(2):391-403. PubMed ID: 29248978 [TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of (-)α-bisabolol as a promising agent against Leishmania amazonensis. Rottini MM; Amaral AC; Ferreira JL; Silva JR; Taniwaki NN; Souza Cda S; d'Escoffier LN; Almeida-Souza F; Hardoim Dde J; Gonçalves da Costa SC; Calabrese Kda S Exp Parasitol; 2015 Jan; 148():66-72. PubMed ID: 25448354 [TBL] [Abstract][Full Text] [Related]
17. Dissimilar peptidase production by avirulent and virulent promastigotes of Leishmania braziliensis: inference on the parasite proliferation and interaction with macrophages. Lima AK; Elias CG; Souza JE; Santos AL; Dutra PM Parasitology; 2009 Sep; 136(10):1179-91. PubMed ID: 19631015 [TBL] [Abstract][Full Text] [Related]
18. HIV aspartic peptidase inhibitors are effective drugs against the trypomastigote form of the human pathogen Trypanosoma cruzi. Sangenito LS; Gonçalves DS; Seabra SH; d'Avila-Levy CM; Santos AL; Branquinha MH Int J Antimicrob Agents; 2016 Oct; 48(4):440-4. PubMed ID: 27499433 [TBL] [Abstract][Full Text] [Related]
19. In vitro Assessment of Camphor Hydrazone Derivatives as an Agent Against Leishmania amazonensis. da Silva ET; de Andrade GF; Araújo ADS; Almeida ADC; Coimbra ES; de Souza MVN Acta Parasitol; 2020 Mar; 65(1):203-207. PubMed ID: 31832921 [TBL] [Abstract][Full Text] [Related]
20. Antileishmanial activity of essential oil and 6,7-dehydroroyleanone isolated from Tetradenia riparia. Demarchi IG; Thomazella MV; de Souza Terron M; Lopes L; Gazim ZC; Cortez DA; Donatti L; Aristides SM; Silveira TG; Lonardoni MV Exp Parasitol; 2015 Oct; 157():128-37. PubMed ID: 26116864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]